Intensive Description of Burns Regenerative Treatment with M

BRT with MEBT/MEBO is an entirely new burns treatment technique that operates in compliance with the law of life. BRT was invented on the basis of academic thoughts according to the pathogenesis of burns. This new therapy comprises a complete set of theories and techniques for the local and systemic treatment of burns. The profile of this therapy is that through liquefaction and removal of the necrotic tissue, culture and regeneration of residual viable skin, and through repair and replication, burns wounds are finally healed. Wounds are not kept in a dry environment as required in conventional surgical burn therapy, but in a physiological moist environment.

For local treatment, BRT with MEBT/MEBO is associated with MEBO. For systemic treatment, it forms an independent system in compliance with the law of life, including its theory, methodology and therapeutic results. In local treatment, BRT resolved the problems of wound pain and complete regenerative healing of deep second-degree wounds. Through reducing bacterial toxicity by variation, and promoting local resistance to infections, BRT with MEBT/MEBO effectively prevented and controlled wound infections. Through creating a physiological moist environment and good nutrition supply, BRT with MEBT/MEBO promoted the culture and differentiation of stem cells from the epithelia and relevant tissues in the residual fat layer and finally healed the wounds to full-thickness. Furthermore, exposed bone wounds from burns can also be healed by drilling on the bone in combination with MEBO application, culturing granulation tissue to cover bone and heal the wounds. In systemic treatment, measures of strengthening cardiac function and removing the obstacles in blood supply of renal parenchymal blood vessels are adopted, and then blood volume replacement and comprehensive antishock measures are taken. According to the severity of burn case, effective broad-spectrum antibiotics are applied to control infections at an early stage, but the antibiotics are stopped in order to protect the function of the organs at days 7~10 postburn.

Due to the remarkable effect of this therapy, it has been introduced in Syria, the United Arab Emirates, Thailand, the Republic of Korea, Singapore, etc., and has achieved great clinical successes in these countries. Now BRT with MEBT/MEBO is spreading its academic thought as well as its technology to the United States and European countries. At the Congress of the Pan-Arab Association for Burns and Plastic Surgery held in the United Arab Emirates on February 22, 2000, specialists from dozens of countries gave presentations on their research on BRT with MEBT/MEBO.